The oncogenic signalosome: SQSTM1/p62 as a master integrator of signaling, metabolism, and autophagy in cancer

Park I, Chung J, Walsh CT, Yun Y, Strominger JL, Shin J (1995) Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region. Proc Natl Acad Sci USA 92:12338–12342. https://doi.org/10.1073/pnas.92.26.12338

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joung I, Strominger JL, Shin J (1996) Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain. Proc Natl Acad Sci USA 93:5991–5995. https://doi.org/10.1073/pnas.93.12.5991

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishii T, Itoh K, Sato H, Bannai S (1999) Oxidative stress-inducible proteins in macrophages. Free Radic Res 31:351–355. https://doi.org/10.1080/10715769900300921

Article  CAS  PubMed  Google Scholar 

Yanagawa T, Yuki K, Yoshida H, Bannai S, Ishii T (1997) Phosphorylation of A170 stress protein by casein kinase II-like activity in macrophages. Biochem Biophys Res Commun 241:157–163. https://doi.org/10.1006/bbrc.1997.7783

Article  CAS  PubMed  Google Scholar 

Ciani B, Layfield R, Cavey JR, Sheppard PW, Searle MS (2003) Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget’s disease of bone. J Biol Chem 278:37409–37412. https://doi.org/10.1074/jbc.M307416200

Article  CAS  PubMed  Google Scholar 

Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW (2004) Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 24:8055–8068. https://doi.org/10.1128/MCB.24.18.8055-8068.2004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Isogai S, Morimoto D, Arita K, Unzai S, Tenno T, Hasegawa J, Sou YS, Komatsu M, Tanaka K, Shirakawa M, Tochio H (2011) Crystal structure of the ubiquitin-associated (UBA) domain of p62 and its interaction with ubiquitin. J Biol Chem 286:31864–31874. https://doi.org/10.1074/jbc.M111.259630

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282:24131–24145. https://doi.org/10.1074/jbc.M702824200

Article  CAS  PubMed  Google Scholar 

Ichimura Y, Kumanomidou T, Sou YS, Mizushima T, Ezaki J, Ueno T, Kominami E, Yamane T, Tanaka K, Komatsu M (2008) Structural basis for sorting mechanism of p62 in selective autophagy. J Biol Chem 283:22847–22857. https://doi.org/10.1074/jbc.M802182200

Article  PubMed  Google Scholar 

Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S, Hamazaki J, Nishito Y, Iemura S, Natsume T, Yanagawa T, Uwayama J, Warabi E, Yoshida H, Ishii T, Kobayashi A, Yamamoto M, Yue Z, Uchiyama Y, Kominami E, Tanaka K (2007) Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131:1149–1163. https://doi.org/10.1016/j.cell.2007.10.035

Article  CAS  PubMed  Google Scholar 

Itakura E, Mizushima N (2011) p62 targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding. J Cell Biol 192:17–27. https://doi.org/10.1083/jcb.201009067

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on Huntingtin-induced cell death. J Cell Biol 171:603–614. https://doi.org/10.1083/jcb.200507002

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kirkin V, McEwan DG, Novak I, Dikic I (2009) A role for ubiquitin in selective autophagy. Mol Cell 34:259–269. https://doi.org/10.1016/j.molcel.2009.04.026

Article  CAS  PubMed  Google Scholar 

Katsuragi Y, Ichimura Y, Komatsu M (2016) Regulation of the Keap1–Nrf2 pathway by p62/SQSTM1. Curr Opin Toxicol 1:54–61. https://doi.org/10.1016/j.cotox.2016.09.005

Article  Google Scholar 

Ichimura Y, Komatsu M (2018) Activation of p62/SQSTM1-Keap1-nuclear factor erythroid 2-related factor 2 pathway in cancer. Front Oncol 8:210. https://doi.org/10.3389/fonc.2018.00210

Article  PubMed  PubMed Central  Google Scholar 

Inami Y, Waguri S, Sakamoto A, Kouno T, Nakada K, Hino O, Watanabe S, Ando J, Iwadate M, Yamamoto M, Lee MS, Tanaka K, Komatsu M (2011) Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol 193:275–284. https://doi.org/10.1083/jcb.201102031

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ling J, Kang Y, Zhao R, Xia Q, Lee DF, Chang Z, Li J, Peng B, Fleming JB, Wang H, Liu J, Lemischka IR, Hung MC, Chiao PJ (2012) KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 21:105–120. https://doi.org/10.1016/j.ccr.2011.12.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Umemura A, He F, Taniguchi K, Nakagawa H, Yamachika S, Font-Burgada J, Zhong Z, Subramaniam S, Raghunandan S, Duran A, Linares JF, Reina-Campos M, Umemura S, Valasek MA, Seki E, Yamaguchi K, Koike K, Itoh Y, Diaz-Meco MT, Moscat J, Karin M (2016) p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells. Cancer Cell 29:935–948. https://doi.org/10.1016/j.ccell.2016.04.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ieni A, Pizzimenti C, Broggi G, Caltabiano R, Germano A, Barbagallo GMV, Vigneri P, Giuffre G, Tuccari G (2022) Immunoexpression of p62/SQSTM1/Sequestosome-1 in human primary and recurrent IDH1/2 wild-type glioblastoma: a pilot study. Oncol Lett 24:336. https://doi.org/10.3892/ol.2022.13456

Article  CAS  PubMed  PubMed Central  Google Scholar 

Philipson E, Engstrom C, Naredi P, Bourghardt Fagman J (2022) High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer. BMC Cancer 22:347. https://doi.org/10.1186/s12885-022-09468-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Valencia T, Kim JY, Abu-Baker S, Moscat-Pardos J, Ahn CS, Reina-Campos M, Duran A, Castilla EA, Metallo CM, Diaz-Meco MT, Moscat J (2014) Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. Cancer Cell 26:121–135. https://doi.org/10.1016/j.ccr.2014.05.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakamura K, Kimple AJ, Siderovski DP, Johnson GL (2010) PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation. J Biol Chem 285:2077–2089. https://doi.org/10.1074/jbc.M109.065102

Article  CAS  PubMed  Google Scholar 

Duran A, Amanchy R, Linares JF, Joshi J, Abu-Baker S, Porollo A, Hansen M, Moscat J, Diaz-Meco MT (2011) p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell 44:134–146. https://doi.org/10.1016/j.molcel.2011.06.038

Article  CAS  PubMed  PubMed Central  Google Scholar 

Linares JF, Duran A, Yajima T, Pasparakis M, Moscat J, Diaz-Meco MT (2013) K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells. Mol Cell 51:283–296. https://doi.org/10.1016/j.molcel.2013.06.020

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kehl SR, Soos BLA, Saha B, Choi SW, Herren AW, Johansen T, Mandell MA (2019) TAK 1 converts Sequestosome 1/p62 from an autophagy receptor to a signaling platform. EMBO Rep 20:e46238. https://doi.org/10.15252/embr.201846238

Article  CAS  PubMed 

Comments (0)

No login
gif